Company: INMB
Filing Date: 2025-12-08
Form Type: 8-K
Source: 0001213900-25-119217
Chunk: 2

Company: Inmune Bio, Inc.
Filing Date: 2025-12-08
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01. Financial Statements and Exhibits

(d) Exhibits

  Number      Description                                                                                                                       
     4.1      Amendment No. 5 to Rights Agreement, dated as of December 5, 2025, between the Company and VStock Transfer LLC, as Rights Agent.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                       

SIGNATURE

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

  Date: December 8, 2025      INMUNE BIO INC.                               
 ────────────────────────────────────────────────────────────────────────────
                              By:                  /s/ David Moss           
                                                   David Moss               
                                                   Chief Executive Officer